Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques

@article{ONeill2004PreclinicalEO,
  title={Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques},
  author={Alex J. O’Neill and Ian Chopra},
  journal={Expert Opinion on Investigational Drugs},
  year={2004},
  volume={13},
  pages={1045 - 1063}
}
The defining property of an antibacterial agent is its ability to selectively interfere with bacterial growth and/or survival. Consequently, a considerable and crucial part of the preclinical evaluation of any novel antibacterial drug involves judging and characterising its effects on bacteria in vitro. These critical stages in drug development are sometimes made to appear somewhat trivial, sandwiched as they are between the highly demanding antibacterial discovery process and the formidable… 

Antibacterial activity and mechanism of action of lipophilic antioxidants.

TLDR
The potent and selective antibacterial activity, and low resistance potential upon extended subculture, suggest that these compounds could be used topically in combination with gentamicin to treat infected wounds.

Revisiting unexploited antibiotics in search of new antibacterial drug candidates: the case of γ-actinorhodin

TLDR
It is shown that γ-actinorhodin possesses many of the requisite properties of an antibacterial drug, displaying potent and selective bactericidal activity against key Gram-positive pathogens and a degree of in vivo efficacy in an invertebrate model of infection.

New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria

TLDR
None of the antibacterial agents currently in clinical trials that encompass Gram-negative bacteria in their spectrum of activity possess sufficiently novel modes of action to circumvent extant antibiotic resistance mechanisms.

Natural Products as a Source for Novel Antibiotics.

  • M. Moloney
  • Biology
    Trends in pharmacological sciences
  • 2016

Identification of a Novel Protein Synthesis Inhibitor Active against Gram‐Positive Bacteria

TLDR
The identification of a benzothiazolium salt, ABTZ‐1, that displayed potent antibacterial activity against Gram‐positive pathogens and represents a promising new class of antibacterial agents.

An Improved Small-Molecule Inhibitor of FtsZ with Superior In Vitro Potency, Drug-Like Properties, and In Vivo Efficacy

TLDR
Optimized derivatives of 3-methoxybenzamide derivatives may yield a first-in-class FtsZ inhibitor for the treatment of antibiotic-resistant staphylococcal infections.

XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity.

TLDR
XF-73 exhibited rapid membrane-perturbing activity, which is likely to be responsible for inhibition of macromolecular synthesis and the death of staphylococci exposed to the drug.

A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents.

TLDR
NFAs have many useful antimycobacterial properties applicable to TB chemotherapy and probably possess a unique mode of action that results in good activity against active and dormant M. tuberculosis.

Challenges of Antibacterial Discovery

  • L. Silver
  • Biology
    Clinical Microbiology Reviews
  • 2011
TLDR
The purpose of this review is to underscore and illustrate those scientific problems unique to the discovery and optimization of novel antibacterial agents that have adversely affected the output of the effort.

The Antibiotic Future

TLDR
The future fate of antibiotic discovery will depend upon the degree to which the rate limiting steps of discovery are fully recognized, and the discovery technology turns to overcoming these blockades.
...

References

SHOWING 1-10 OF 148 REFERENCES

Screening of natural products for antimicrobial agents

  • L. SilverK. Bostian
  • Biology
    European Journal of Clinical Microbiology and Infectious Diseases
  • 2005
TLDR
A balance is struck between screening for inhibitors of rationally chosen targets for which clinically useful inhibitors are not yet available, and screening more broadly to ensure that rare activities of unanticipated mode-of-action are not missed.

Discovery and development of new antimicrobial agents

  • T. Gootz
  • Biology, Chemistry
    Clinical Microbiology Reviews
  • 1990
TLDR
Those factors that have influenced the rapid proliferation of new antimicrobial agents, including the discovery of new lead structures from natural products and the impact of bacterial resistance development in the clinical setting are discussed.

New (and not so new) antibacterial targets - from where and when will the novel drugs come?

  • S. Projan
  • Biology
    Current opinion in pharmacology
  • 2002

Anti-staphylococcal activity and mode of action of clofazimine.

TLDR
Clofazimine is a potent anti-staphylococcal agent that appears to be a membrane-disrupting agent and does not inhibit RNA polymerase.

Novel antibacterials: a genomics approach to drug discovery.

TLDR
A number of target classes in which genomics has contributed to its identification are described, including Fatty acid biosynthesis, a known antibacterial target, but genomics showed which genes in that pathway had the appropriate spectrum to be considered as therapeutic targets.

Development of a Screening Assay to Measure the Loss of Antibacterial Activity in the Presence of Proteins: Its Use in Optimizing Compound Structure

TLDR
The method described in this report can be used to optimize compound design and minimize this undesirable effect of losing antibacterial potency due to wide variation in the apparent stoichiometry for protein-ligand association.

Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus.

Triclosan, a widely used antibacterial agent, possesses potent activity against Staphylococcus aureus. This study reports on an investigation of the antibacterial target of triclosan in this

Detection of novel secondary metabolites.

TLDR
This review focuses on the genesis and development of the gamut of methodologies that have led to the successful detection of the wide variety of novel secondary metabolites that include antibacterial, antigungal, antiviral and antitumour antibiotics, enzyme inhibitors, pharmacologically and immunologically active agents, products useful in agriculture and animal husbandry, microbial regulators, and other compounds for which no bioactive role has yet been found.

Peptide Deformylase as an Antibacterial Drug Target: Target Validation and Resistance Development

TLDR
It is concluded that PDF may not be an optimal target for broad-spectrum antibacterial agents after several lines of experimental evidence indicate that these inhibitors indeed interfere with the target enzyme in the bacterial cell.

Applications of therapy in animal models to bacterial infection in human disease.

TLDR
Animal models have proven to be invaluable in bridging the gap between in vitro susceptibility testing of an antibiotic and anticipating results obtained in clinical studies, and suggesting which antimicrobials would not be expected to be of therapeutic benefit in man.
...